findmyKOL
Clinical trialNCT03400787CompletedInterventional

Latera RCT - Latera vs. Sham Control for Lateral Nasal Valve Collapse

SponsorSpirox, Inc.Enrollment137Nasal BreathingNasal Valve Collapse
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The primary objective of the LATERA RCT is to demonstrate the superiority of the Latera Implant to improve nasal breathing, compared with a Sham Control procedure.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Sacramento Ent

    Roseville, California, United States

  • Breathe Clear Institute

    Torrance, California, United States

  • Ent of Ga

    Atlanta, Georgia, United States

  • Chicago Nasal and Sinus Center

    Chicago, Illinois, United States

  • Michiana Sleep and Ent Solutions

    South Bend, Indiana, United States

  • Albany Ent & Allergy

    Albany, New York, United States

  • Piedmont Ent

    Winston-Salem, North Carolina, United States

  • Texas Ent Specialist

    Houston, Texas, United States

  • Ent Associates of Texas

    McKinney, Texas, United States

  • Texas Facial Plastics and Ent

    San Antonio, Texas, United States

  • Ogden Clinic

    Ogden, Utah, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Nov 2017
Primary completion
1 Feb 2019
Completion
23 Dec 2020
Last update posted
9 Feb 2021
Registered enrollment
137
Registry id
NCT03400787

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.